100 related articles for article (PubMed ID: 7729951)
1. Cdk1 is a marker of proliferation in human lymphoid cells.
Wołowiec D; Deviller P; Simonin D; Souchier C; Rimokh R; Benchaib M; Bryon PA; Ffrench M
Int J Cancer; 1995 May; 61(3):381-8. PubMed ID: 7729951
[TBL] [Abstract][Full Text] [Related]
2. Differential cyclin-dependent kinase expression and activation in human colon cancer.
Salh B; Bergman D; Marotta A; Pelech SL
Anticancer Res; 1999; 19(1B):741-8. PubMed ID: 10216486
[TBL] [Abstract][Full Text] [Related]
3. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the major cyclin-dependent kinases, cdk2 and cdc2, during cell cycle progression in human lymphocytes exposed to heptachlor.
Chuang LF; Rought SE; Chuang RY
In Vivo; 1999; 13(6):455-61. PubMed ID: 10757037
[TBL] [Abstract][Full Text] [Related]
6. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
Carstens CP; Krämer A; Fahl WE
Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
8. ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells.
Urbanowicz-Kachnowicz I; Baghdassarian N; Nakache C; Gracia D; Mekki Y; Bryon PA; Ffrench M
Int J Cancer; 1999 Jul; 82(1):98-104. PubMed ID: 10360827
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyclic AMP on components of the cell cycle machinery regulating DNA synthesis in cultured astrocytes.
Gagelin C; Toru-Delbauffe D; Gavaret JM; Pierre M
J Neurochem; 1999 Nov; 73(5):1799-805. PubMed ID: 10537037
[TBL] [Abstract][Full Text] [Related]
11. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes.
Baghdassarian N; Peiretti A; Devaux E; Bryon PA; Ffrench M
Cell Growth Differ; 1999 Jun; 10(6):405-12. PubMed ID: 10392902
[TBL] [Abstract][Full Text] [Related]
12. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1.
Casagrande F; Darbon JM
Biochem Pharmacol; 2001 May; 61(10):1205-15. PubMed ID: 11322924
[TBL] [Abstract][Full Text] [Related]
13. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer.
Yamamoto H; Monden T; Ikeda K; Izawa H; Fukuda K; Fukunaga M; Tomita N; Shimano T; Shiozaki H; Monden M
Br J Cancer; 1995 Jun; 71(6):1231-6. PubMed ID: 7779716
[TBL] [Abstract][Full Text] [Related]
15. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue.
Wołowiec D; Benchaib M; Pernas P; Deviller P; Souchier C; Rimokh R; Felman P; Bryon PA; Ffrench M
Leukemia; 1995 Aug; 9(8):1382-8. PubMed ID: 7643628
[TBL] [Abstract][Full Text] [Related]
17. Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity.
Begemann M; Kashimawo SA; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
Anticancer Res; 1998; 18(4A):2275-82. PubMed ID: 9703866
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
[TBL] [Abstract][Full Text] [Related]
19. Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain.
Roublevskaia IN; Polevoda BV; Ludlow JW; Haake AR
Anticancer Res; 2000; 20(5A):3163-7. PubMed ID: 11062738
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
